Surgical Innovations Group plc (AIM:SUN)
London · Delayed Price · Currency is GBP · Price in GBX 0.4800
+0.0300 (6.67%)
May 8, 2026, 12:52 PM GMT
AIM:SUN Revenue
In the year 2025, Surgical Innovations Group had annual revenue of 11.60M GBP, down -2.87%. Surgical Innovations Group had revenue of 5.46M in the half year ending December 31, 2025, a decrease of -14.25%.
Revenue
11.60M
Revenue Growth
-2.87%
P/S Ratio
0.36
Revenue / Employee
136.49K
Employees
85
Market Cap
4.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.60M | -343.00K | -2.87% |
| Dec 31, 2024 | 11.95M | -69.00K | -0.57% |
| Dec 31, 2023 | 12.01M | 674.00K | 5.94% |
| Dec 31, 2022 | 11.34M | 2.21M | 24.26% |
| Dec 31, 2021 | 9.13M | 2.80M | 44.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 45.77B |
| GSK plc | 32.78B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Cambridge Nutritional Sciences | 8.06M |
| Futura Medical | 7.93M |
| OptiBiotix Health | 1.15M |
| Feedback | 849.62K |
Surgical Innovations Group News
- 15 days ago - Full Year 2025 Surgical Innovations Group PLC Earnings Presentation Transcript - GuruFocus
- 6 months ago - Half Year 2025 Surgical Innovations Group PLC Investor Briefing Transcript - GuruFocus
- 1 year ago - AIM Market Roundup: Gelion, Surgical Innovations, Deltex Medical - The Armchair Trader